SCOPUS 정보 검색 플랫폼

Cephalalgia

Volumn 21, Issue 2, 2001, Pages 129-136

Meta-analysis of rizatriptan efficacy in randomized controlled clinical trials

(4) Ferrari, M D a Loder, E b McCarroll, K A c Lines, Christopher R c,d

a LEIDEN UNIVERSITY MEDICAL CENTER (Netherlands)

b and Red Sox Foundation and Massachusetts General Hospital Home Base Program (United States)

c MERCK RESEARCH LABORATORIES (United States)

d NONE (United States)

Author keywords

5 HT1B 1D receptor agonist; Migraine; Rizatriptan

Indexed keywords

PLACEBO; RIZATRIPTAN;

ADULT; ANALGESIA; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISABILITY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; MIGRAINE; PHASE 3 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; CLINICAL TRIALS, PHASE III; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIGRAINE DISORDERS; RANDOMIZED CONTROLLED TRIALS; TREATMENT OUTCOME; TRIAZOLES; TRYPTAMINES;

EID: 0034989580 PISSN: 03331024 EISSN: None Source Type: Journal
DOI: 10.1046/j.1468-2982.2001.00169.x Document Type: Article

Times cited : (48)

References (24)

1
- 0030805366
- How to define the best efficacy parameters for migraine
- (1997) Cephalalgia , vol.17 , Issue.SUPPL. 17 , pp. 6-9
- Tfelt-Hansen, P.¹

2
- 0032989190
- How to assess and compare drugs in the management of migraine: Success rates in terms of response and recurrence
- (1999) Cephalalgia , vol.19 , Issue.SUPPL. 23 , pp. 2-8
- Ferrari, M.¹

3
- 0033063645
- Efficacy definitions for migraine studies
- (1999) Cephalalgia , vol.19 , pp. 248-249
- Goldstein, D.J.¹ Offen, W.W.² Moster, M.B.³

4
- 0031899682
- Rizatriptan (MAXALT) for the acute treatment of migraine and migraine recurrence. A placebo-controlled, outpatient study
- (1998) Headache , vol.38 , pp. 281-287
- Teall, J.¹ Tuchman, M.² Cutler, N.³ Gross, M.⁴ Willoughby, E.⁵ Smith, E.⁶

5
- 0031751088
- A placebo-controlled crossover study of rizatriptan in the treatment of multiple migraine attacks
- (1998) Neurology , vol.51 , pp. 773-781
- Kramer, M.S.¹ Matzura-Wolfe, D.² Polis, A.³ Getson, A.⁴ Amaraneni, P.G.⁵ Solbach, M.P.⁶

6
- 0032407703
- Oral rizatriptan versus oral sumatriptan: A direct comparative study in the acute treatment of migraine
- (1998) Headache , vol.38 , pp. 748-755
- Tfelt-Hansen, P.¹ Teall, J.² Rodriguez, F.³ Giacorazzo, M.⁴ Paz, J.⁵ Malbecq, W.⁶

7
- 0032423808
- Crossover comparison of rizatriptan 5 mg and 10 mg vs sumatriptan 25 mg and 50 mg in migraine
- (1998) Headache , vol.38 , pp. 737-747
- Goldstein, J.¹ Ryan, R.² Jiang, K.³ Getson, A.⁴ Norman, B.⁵ Block, G.A.⁶ Lines, C.⁷

8
- 0032987716
- Efficacy and safety of rizatriptan wafer for the acute treatment of migraine
- (1999) Cephalalgia , vol.19 , pp. 525-530
- Ahrens, S.P.¹ Farmer, M.V.² Williams, D.L.³ Willoughby, E.⁴ Block, G.A.⁵ Visser, W.H.⁶

9
- 0004883374
- Maxalt (rizatriptan) tablets
- Montvale, New Jersey: Medical Economics Company
- (1999) Physicians Desk Reference , pp. 1822-1827

10
- 0003663972
- Geneva: IFPMA ICH Secretariat
- (1996) Guidelines for Good Clinical Practice

11
- 0346031709
- Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain
- (1988) Cephalalgia , vol.8 , Issue.SUPPL. 7 , pp. 1-96

12
- 0029824318
- Rizatriptan vs sumatriptan in the acute treatment of migraine
- (1996) Arch Neurol , vol.53 , pp. 1132-1137
- Visser, W.H.¹ Terwindt, G.M.² Reines, S.A.³ Jiang, K.⁴ Lines, C.R.⁵ Ferrari, M.⁶

13
- 0030769110
- Double-blind, placebo-controlled, dose-finding study of rizatriptan (MK-462) in the acute treatment of migraine
- (1997) Cephalalgia , vol.17 , pp. 647-651
- Gijsman, H.¹ Kramer, M.S.² Sargent, J.³ Tuchman, N.⁴ Matzura-Wolfe, D.⁵ Polis, A.⁶ Teall, J.⁷ Block, G.⁸

14
- 17544403877
- Comparison of rizatriptan 10 mg vs. zolmitriptan 2.5 mg in the acute treatment of migraine
- (2000) Cephalalgia , vol.20 , pp. 455-461
- Pascual, J.¹ Vega, P.² Diener, H.-C.³ Allen, C.⁴ Vrijens, F.⁵ Patel, K.⁶

15
- 0032825839
- Comparison of rizatriptan 10 mg vs. naratriptan 2.5 mg in migraine
- (1999) European Neurol , vol.42 , pp. 173-179
- Bomhof, M.¹ Paz, J.² Legg, N.³ Allen, C.⁴ Vandormael, K.⁵ Patel, K.⁶

16
- 84965632039
- Guidelines for controlled trials of drugs in migraine
- (1991) Cephalalgia , vol.11 , pp. 1-12

17
- 0032421660
- Efficacy and safety of rizatriptan versus standard care during long-term treatment for migraine
- (1998) Headache , vol.38 , pp. 764-771
- Block, G.A.¹ Goldstein, J.² Polis, A.³ Reines, S.A.⁴ Smith, M.E.⁵

18
- 0032481904
- Migraine
- (1998) Lancet , vol.351 , pp. 1043-1051
- Ferrari, M.D.¹

19
- 0032770477
- Migraine: A comprehensive review of new treatment options
- (1999) Pharmacotherapy , vol.19 , pp. 957-973
- Weitzel, K.W.¹ Thomas, M.L.² Small, R.E.³ Goode, J.R.⁴

20
- 0001756715
- Low headache recurrence with naratriptan: Clinical parameters related to recurrence
- (1998) Headache , vol.38 , pp. 405
- Sheftell, F.¹ Watson, C.² Pait, D.G.³ O'Quinn, S.⁴ Winter, P.⁵

21
- 0032907627
- 1B/1D receptor agonist for the treatment of migraine
- (1999) Exp Opin Invest Drugs , vol.8 , pp. 671-685
- Dahlof, C.¹ Lines, C.²

22
- 0004851227
- Imitrex (sumatriptan) tablets
- Montvale, New Jersey: Medical Economics Company
- (1999) Physicians Desk Reference , pp. 1141-1145

23
- 0004873269
- Zomig (zolmitriptan) tablets
- Montvale: New Jersey, Medical Economics Company
- (1999) Physicians Desk Reference , pp. 1141-1145

24
- 0004845170
- Amerge (naratriptan) tablets
- Montvale, New Jersey: Medical Economics Company
- (1999) Physicians Desk Reference , pp. 1086-1090

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.